These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8996451)

  • 1. Toxoid vaccine for pertussis.
    He Q; Viljanen MK; Arvilommi H; Mertsola J
    Lancet; 1997 Jan; 349(9045):136-7; author reply 137-8. PubMed ID: 8996451
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxoid vaccine for pertussis.
    Preston NW; Matthews RC
    Lancet; 1997 Jan; 349(9045):137; author reply 137-8. PubMed ID: 8996452
    [No Abstract]   [Full Text] [Related]  

  • 3. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned.
    Schneerson R; Robbins JB; Taranger J; Lagergård T; Trollfors B
    Lancet; 1996 Nov; 348(9037):1289-92. PubMed ID: 8909384
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxoid vaccine for pertussis.
    von König CH; Schmitt HJ
    Lancet; 1997 Jan; 349(9045):136; author reply 137-8. PubMed ID: 8996450
    [No Abstract]   [Full Text] [Related]  

  • 6. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
    Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
    Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
    Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
    Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic evaluation of a pertussis toxoid vaccine.
    Robbins JB; Trollfors B; Taranger J; Lagergård T; Zachrisson G; Isacson J
    Dev Biol Stand; 1991; 73():297-303. PubMed ID: 1778322
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular engineering of pertussis toxoid.
    Burnette WN; Mar VL; Bartley TD; Kaslow HR; Cieplak W; Keith JM; Sato H; Burns DL; Arciniega JL; Shahin RD
    Dev Biol Stand; 1991; 73():75-8. PubMed ID: 1778336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Timing of the 2d diphtheria-pertussis-tetanus vaccination with special reference to the prevention of pertussis].
    Erdös L; Solt K; Kiss I
    Orv Hetil; 1971 Jun; 112(26):1515-7. PubMed ID: 5114730
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
    Heininger U; Stehr K; Christenson P; Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.
    Christie CD; Garrison KM; Kiely L; Gupta RK; Heubi J; Marchant CD
    Clin Infect Dis; 2001 Oct; 33(7):997-1003. PubMed ID: 11528571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-whooping cough vaccination. Contribution of a case series].
    Borselli L; Giraldi P
    Minerva Pediatr; 1988 Feb; 40(2):91-7. PubMed ID: 3260328
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of added toxoids on the antigenicity of H. pertussis vaccines.
    UNGAR J
    Br Med J; 1956 Apr; 1(4971):841-2. PubMed ID: 13304353
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of the pertussis component in the triple vaccine].
    Schümann C; Heinrich H
    Dtsch Gesundheitsw; 1971 Feb; 26(7):323-7. PubMed ID: 5110218
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine.
    Robbins JB; Pittman M; Trollfors B; Lagergard TA; Taranger J; Schneerson R
    Pediatr Infect Dis J; 1993 Oct; 12(10):795-807. PubMed ID: 8284114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.